DK0969816T3 - Fremstilling af pulveragglomerater - Google Patents

Fremstilling af pulveragglomerater

Info

Publication number
DK0969816T3
DK0969816T3 DK98911423T DK98911423T DK0969816T3 DK 0969816 T3 DK0969816 T3 DK 0969816T3 DK 98911423 T DK98911423 T DK 98911423T DK 98911423 T DK98911423 T DK 98911423T DK 0969816 T3 DK0969816 T3 DK 0969816T3
Authority
DK
Denmark
Prior art keywords
preparation
powder agglomerates
agglomerates
powder
Prior art date
Application number
DK98911423T
Other languages
English (en)
Inventor
Tsong-Toh Yang
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25232603&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0969816(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of DK0969816T3 publication Critical patent/DK0969816T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Biophysics (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK98911423T 1997-03-20 1998-03-16 Fremstilling af pulveragglomerater DK0969816T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82112997A 1997-03-20 1997-03-20
PCT/US1998/003799 WO1998041193A1 (en) 1997-03-20 1998-03-16 Preparation of powder agglomerates

Publications (1)

Publication Number Publication Date
DK0969816T3 true DK0969816T3 (da) 2005-03-14

Family

ID=25232603

Family Applications (2)

Application Number Title Priority Date Filing Date
DK03020466T DK1393721T3 (da) 1997-03-20 1998-03-16 Doseringsform af pulveragglomerater
DK98911423T DK0969816T3 (da) 1997-03-20 1998-03-16 Fremstilling af pulveragglomerater

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK03020466T DK1393721T3 (da) 1997-03-20 1998-03-16 Doseringsform af pulveragglomerater

Country Status (25)

Country Link
EP (3) EP1393721B1 (da)
JP (5) JP3901738B2 (da)
KR (1) KR100386055B1 (da)
CN (3) CN1149076C (da)
AR (1) AR011986A1 (da)
AT (2) ATE415149T1 (da)
AU (1) AU741783B2 (da)
CA (3) CA2481868C (da)
CL (1) CL2011000050A1 (da)
CZ (1) CZ295460B6 (da)
DE (2) DE69840277D1 (da)
DK (2) DK1393721T3 (da)
ES (2) ES2234102T3 (da)
HU (2) HU230274B1 (da)
ID (1) ID24472A (da)
IL (1) IL131640A0 (da)
MY (1) MY120725A (da)
NO (1) NO328062B1 (da)
NZ (1) NZ337443A (da)
PL (3) PL204480B1 (da)
PT (2) PT1393721E (da)
SK (1) SK284919B6 (da)
TW (1) TWI221778B (da)
WO (1) WO1998041193A1 (da)
ZA (1) ZA982254B (da)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9723985D0 (en) 1997-11-14 1998-01-14 Zeneca Ltd Pharmaceutical compositions
SE9804000D0 (sv) 1998-11-23 1998-11-23 Astra Ab New composition of matter
SE9804001D0 (sv) 1998-11-23 1998-11-23 Astra Ab New process
US6623760B1 (en) 1999-01-28 2003-09-23 Schering Corporation Method of preparing particles for agglomeration
AR022695A1 (es) * 1999-01-28 2002-09-04 Schering Corp PORTADOR SoLIDO PARTICULADO Y MÉTODO PARA PROVEER CONTROL DE LA PARTICULADA PARA LA DISTRIBUCIoN DE TAMANO DE PARTíCULAS Y DE CONTENIDO AMORFO CONVERTIBLE DURANTE SU PREPARACION
GB9903759D0 (en) * 1999-02-18 1999-04-14 Novartis Ag Organic compounds
GB9904919D0 (en) 1999-03-03 1999-04-28 Novartis Ag Organic compounds
WO2001013885A1 (en) * 1999-08-20 2001-03-01 Norton Healthcare Ltd. Method to produce powders for pulmonary or nasal administration
GB0009612D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Therapeutic formulations
GB0009609D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Therapeutic compositions
GB0009605D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Medicaments
FI20002177A0 (fi) * 2000-10-02 2000-10-02 Orion Yhtymae Oyj Uusi yhdistelmä astman hoitoon
FI20002216A0 (fi) * 2000-10-06 2000-10-06 Orion Yhtymae Oyj Yhdistelmäpartikkelit astman hoitoon
FI20002215A0 (fi) 2000-10-06 2000-10-06 Orion Yhtymae Oyj Yhdistelmäpartikkelit
US6667344B2 (en) 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
ITMI20012174A1 (it) * 2001-10-18 2003-04-18 Univ Parma Polvere per somministrazione nasale di farmaci
US7931022B2 (en) 2001-10-19 2011-04-26 Respirks, Inc. Method and apparatus for dispensing inhalator medicament
EP1452179A1 (en) * 2003-02-27 2004-09-01 CHIESI FARMACEUTICI S.p.A. Novel medicament combination of a highly potent long-lasting beta2-agonist and a corticosteroid
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
EP1654001A2 (en) * 2003-08-05 2006-05-10 Boehringer Ingelheim International GmbH Medicaments for inhalation comprising steroids and a betamimetic
CN1838968A (zh) 2003-08-08 2006-09-27 艾伯吉尼斯公司 针对甲状旁腺激素(pth)之抗体和其用途
US7318925B2 (en) 2003-08-08 2008-01-15 Amgen Fremont, Inc. Methods of use for antibodies against parathyroid hormone
CA2540005A1 (en) * 2003-09-26 2005-04-07 Schering Corporation Pulmonary disease treatment
JP2007509941A (ja) * 2003-10-28 2007-04-19 グラクソ　グループ　リミテッド ラクトース無水物を用いる吸入医薬製剤およびその投与方法
KR100844628B1 (ko) * 2003-12-04 2008-07-07 화이자 프로덕츠 인크. 제약상 다입자의 제조 방법
CA2547597A1 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate compositions with improved stability
SE528121C2 (sv) * 2004-03-29 2006-09-05 Mederio Ag Preparering av torrpulver för på förhand uppmätt DPI
IL168603A (en) * 2005-05-16 2011-05-31 Resdevco Res And Dev Co Pharmaceutical or cosmetic composition for the prevention and treatment of irritation of mucous cells or skin cells
DE102006030166A1 (de) * 2006-06-29 2008-01-10 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tempern
DE102006053375A1 (de) * 2006-11-10 2008-05-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Mischung von Pulvern
TW201024034A (en) 2008-12-30 2010-07-01 Saint Gobain Abrasives Inc Bonded abrasive tool and method of forming
JP2012524815A (ja) * 2009-04-24 2012-10-18 シェーリング コーポレイション 乾燥粉末吸引器において有用な凝集体配合物
PL3111927T3 (pl) 2009-05-29 2020-06-29 Pearl Therapeutics, Inc. Kompozycje do wziewnego podawania środków aktywnych oraz związane z nimi sposoby i systemy
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
GB0918150D0 (en) * 2009-10-16 2009-12-02 Jagotec Ag Improved formulations
PT2560611T (pt) * 2010-04-21 2018-02-07 Chiesi Farm Spa Processo para proporcionar partículas com cargas eletrostáticas reduzidas
SG11201507286QA (en) 2013-03-15 2015-10-29 Pearl Therapeutics Inc Methods and systems for conditioning of particulate crystalline materials
JP6020489B2 (ja) 2014-02-27 2016-11-02 トヨタ自動車株式会社 昇圧コンバータ及びその制御方法
MX392636B (es) 2014-10-31 2025-03-24 Glaxosmithkline Ip Dev Ltd Formulacion en polvo.
KR102794286B1 (ko) * 2016-01-08 2025-04-09 테론 파마슈티칼즈, 인크. 7-아조니아바이사이클로[2.2.1]헵탄 유도체의 건조 분말 흡입기 조성물
CN117122585A (zh) * 2023-07-27 2023-11-28 宁波诺丁汉大学 一种通过振动混合制备干粉吸入团聚物处方制剂方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1520247A (en) 1974-08-10 1978-08-02 Fisons Ltd Pelletised medicament formulations
US4161516A (en) * 1975-07-25 1979-07-17 Fisons Limited Composition for treating airway disease
GB8334494D0 (en) 1983-12-24 1984-02-01 Tanabe Seiyaku Co Carbostyril derivatives
ES2044710T3 (es) * 1990-01-29 1994-01-01 Ciba Geigy Ag Procedimiento y dispositivo de dosificacion de un polvo de granulometria fina.
SE9101090D0 (sv) * 1991-04-11 1991-04-11 Astra Ab Process for conditioning of water-soluble substances
SE9302777D0 (sv) * 1993-08-27 1993-08-27 Astra Ab Process for conditioning substances
DK0613371T3 (da) * 1991-12-18 2002-05-13 Astrazeneca Ab Ny kombination af formoterol og budesonid
DK0674533T3 (da) * 1992-12-18 1999-09-27 Schering Corp Inhalator for medikamenter i pulverform
PT721331E (pt) * 1993-10-01 2002-05-31 Astrazeneca Ab Processo i
IS1736B (is) 1993-10-01 1999-12-30 Astra Ab Aðferð og tæki sem stuðla að aukinni samloðun agna
PE44995A1 (es) * 1994-01-27 1995-12-18 Schering Corp Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias
EP1283035A3 (en) * 1994-12-22 2003-03-19 AstraZeneca AB Therapeutic preparation for inhalation containing parathyroid hormone

Also Published As

Publication number Publication date
PL208480B1 (pl) 2011-05-31
HK1021323A1 (en) 2000-06-09
CN1903179A (zh) 2007-01-31
ID24472A (id) 2000-07-20
PL204480B1 (pl) 2010-01-29
ATE415149T1 (de) 2008-12-15
JP2014037446A (ja) 2014-02-27
HU0600845D0 (en) 2007-01-29
NO994519D0 (no) 1999-09-17
SK128099A3 (en) 2000-06-12
DK1393721T3 (da) 2009-03-30
EP0969816A1 (en) 2000-01-12
CA2282360C (en) 2004-11-09
ES2316681T3 (es) 2009-04-16
PT1393721E (pt) 2009-02-02
JP2006152000A (ja) 2006-06-15
ATE284677T1 (de) 2005-01-15
ES2234102T3 (es) 2005-06-16
PL335742A1 (en) 2000-05-08
AU741783B2 (en) 2001-12-06
NO328062B1 (no) 2009-11-13
CA2282360A1 (en) 1998-09-24
SK284919B6 (sk) 2006-02-02
CA2481868A1 (en) 1998-09-24
EP0969816B1 (en) 2004-12-15
JP3901738B2 (ja) 2007-04-04
JP2010275316A (ja) 2010-12-09
PL192441B1 (pl) 2006-10-31
CN1149076C (zh) 2004-05-12
CL2011000050A1 (es) 2011-06-24
KR20010005520A (ko) 2001-01-15
CN100548277C (zh) 2009-10-14
CZ295460B6 (cs) 2005-08-17
KR100386055B1 (ko) 2003-06-09
CN1552310A (zh) 2004-12-08
CA2706634C (en) 2012-10-23
CA2706634A1 (en) 1998-09-24
NZ337443A (en) 2001-04-27
DE69828155D1 (de) 2005-01-20
DE69828155T2 (de) 2005-12-22
JP2000510478A (ja) 2000-08-15
HUP0002029A2 (hu) 2000-11-28
MY120725A (en) 2005-11-30
AU6537898A (en) 1998-10-12
HU226671B1 (en) 2009-06-29
EP2036544B1 (en) 2016-12-28
EP1393721B1 (en) 2008-11-26
HU230274B1 (hu) 2015-11-30
IL131640A0 (en) 2001-01-28
JP2010248260A (ja) 2010-11-04
JP5523240B2 (ja) 2014-06-18
HK1061359A1 (en) 2004-09-17
CN1257423A (zh) 2000-06-21
CA2481868C (en) 2010-06-15
EP1393721A1 (en) 2004-03-03
WO1998041193A1 (en) 1998-09-24
NO994519L (no) 1999-11-19
HUP0002029A3 (en) 2001-02-28
TWI221778B (en) 2004-10-11
EP2036544A1 (en) 2009-03-18
CN100518718C (zh) 2009-07-29
ZA982254B (en) 1998-09-17
AR011986A1 (es) 2000-09-13
PT969816E (pt) 2005-04-29
DE69840277D1 (de) 2009-01-08
CZ323399A3 (cs) 2000-02-16

Similar Documents

Publication Publication Date Title
DK0969816T3 (da) Fremstilling af pulveragglomerater
EE04420B1 (et) Pulberinhalaator
DK0954282T3 (da) Fremstilling af partikler til inhalation
DK0908449T3 (da) Fremstilling af carotenoider
ID18427A (id) Pengkabut serbuk
DE60023254D1 (de) Kosmetische Kompaktpuder Zusammensetzung
DE69708327D1 (de) Pulverinhalator
ID24486A (id) Komposisi-komposisi oral dari levosimendan
DK0866069T3 (da) Fremstilling af ascorbylmonophosphater
DK0911311T3 (da) Fremstilling af lycopenmetabolitter
DE69812797D1 (de) Hitzehärtende Pulverlackzusammensetzung
DE59909297D1 (de) Carbonyleisensilizid-Pulver
DE59810370D1 (de) Pulverlack
DK0875579T3 (da) Fremstilling af L(+)-laktat
DE69834091D1 (de) Kosmetische Zubereitung
ATE217335T1 (de) Farbige pulverförmige beschichtungsmasse
DK1001962T3 (da) Fremstilling af avermectinforbindelser
NO20003182L (no) FremgangsmÕte for inhalering av pulverstoffer
ID19844A (id) Komponen tumbukan
DK1088010T3 (da) Fremstilling af polyolefiner
DK0882722T3 (da) Fremstilling af alpha-tocopherol
ATE258011T1 (de) Benetzbare pulverformulierungen
DK0927163T3 (da) Fremstilling af 1-butyl-4-piperidinylmethylamin
DK0859001T3 (da) Fremstilling af oxazolderivater
ID23295A (id) Komposisi bedak bubuk talek